Status:
RECRUITING
Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients
Lead Sponsor:
Yonsei University
Collaborating Sponsors:
LG Electronics Inc.
Conditions:
Rhinitis Allergic
Eligibility:
All Genders
19-60 years
Phase:
NA
Brief Summary
This study targets adult patients between the ages of 19 and 60 who were diagnosed with allergic rhinitis caused by indoor inhalation antigens. Patients with moderate to severe and persistent allergic...
Detailed Description
This study targets adult patients between the ages of 19 and 60 who were diagnosed with allergic rhinitis caused by indoor inhalation antigens. Patients with moderate to severe and persistent allergic...
Eligibility Criteria
Inclusion
- adults aged 19 to 60
- A person with moderate-severe persistent allergic rhinitis diagnosed by an allergy specialist or otolaryngologist and maintained without any change in treatment for more than one month
- Total nasal symptom Score ≥ 8
- Patients with allergic rhinitis caused by indoor inhalation antigen antigens (House dust mites ± If the wheal size of the pet skin test is greater than 3mm or the concentration of specific IgE measured by ImmunoCAP ≥ 0.35 kUA/L)
- A person who spends at least 8 hours/day per week in the home where the cleaner will be installed
- A person with a wi-fi installed in the home where the purifier will be installed
- A person who can read and write in Korean
- A person who fully explains the contents, decides to participate in the study according to his/her free will, and signs a written consent form approved by each agency IRB
Exclusion
- Patients sensitized to seasonal antigens (tree, grass or weed pollen)
- Rhinitis patients caused by causes other than allergic rhinitis (drug rhinitis, vascular rhinitis, infectious rhinitis, etc.)
- Anyone who has required more than 2 weeks of systemic steroid use in the last 3 months
- A person taking antihistamines for reasons other than rhinitis (chronic urticaria, etc.)
- Those with anatomical abnormalities that cause nasal congestion, such as non-segmental curvature and non-segmental species
- A person who has a plan to move during the study period or is scheduled to leave where air purifiers are installed for at least five consecutive days (e.g., travel, business trip, etc.)
- A person who has already used an air purifier within the last three months
- Pregnant women, lactating women, persons lacking decision-making ability, persons accommodated in facilities
- A person whose researcher is deemed unfit to participate in clinical research due to other reasons
Key Trial Info
Start Date :
March 11 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 20 2025
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06890572
Start Date
March 11 2025
End Date
June 20 2025
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University
Seoul, South Korea, 03722